Iambic: $100 Million Raised To Advance AI-Discovered Therapeutics And Platform Technologies
By Amit Chowdhry ● Nov 10, 2025
Iambic, a clinical-stage life science and technology company headquartered in San Diego, announced that it has raised more than $100 million in an oversubscribed financing round. The round drew participation from a broad group of new and existing investors spanning life sciences, growth equity, technology, and sovereign wealth funds. Participating investors included Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Mubadala, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsini Goodrich & Rosati, and others.